TASMANIA will play a key role in a trial as to whether vitamin D can prevent multiple sclerosis in people at risk of developing the disease.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
Tasmania has the highest incidence of MS-an inflammatory disease that affects the brain and spinal cord- in Australia.
The study was launched by Franklin Labor MHR Julie Collins in Hobart today.
``It is great that Tasmanian patients will not only contribute to this research, but could also be among the first to benefit from its results,'' Ms Collins said.
The study will look at the effect of using vitamin D supplementation to prevent a diagnosis of MS after someone first shows symptoms.
It will also look at appropriate dosage levels and safety.
Royal Hobart Hospital lead investigator Professor Bruce Taylor said the trial was the first of its kind in the world.
``Australia has a very real opportunity here to help reduce the impact of MS around the world,'' he said.
Trial subjects will be recruited through neurologists.
The trial is being funded by MS Research Australia.
